BCL2 and neoplasm: Here, we investigated tumor-specific BCL2 expression with the automated quantitative analysis (AQUA) scoring system using the multiplex immunofluorescent (IF) imaging to assess the prognostic impact of quantitative BCL2 expression in patients with newly diagnosed DLBCL treated with R-CHOP.